AI brief of an SEC Form 8-K · Scilex Holding Co (SCLX)

Scilex agrees to sell Vivasor preferred stock for $12.0 million in tranches through June 2027

Neutral Impact 4 of 5 m&a Written later

Scilex Holding Company agreed on July 18, 2026 to sell Vivasor Holding Company shares of Vivasor preferred stock it had acquired in January 2026, for an aggregate price of $11,999,762.28. Payment is scheduled in tranches through June 30, 2027, and Vivasor may pay in cash, in shares of Datavault AI common stock, or a combination. The buyer is led by Scilex CEO Dr. Henry Ji, who is also Vivasor's CEO, a related-party arrangement shareholders may want to weigh.

Key points

  • Agreement dated July 18, 2026; Scilex sells 6,101,468 Series A-1 and 355,919 Series A-2 Vivasor preferred shares
  • Aggregate purchase price of $11,999,762.28, with $999,980.97 due July 18, 2026 and $4,999,901.10 due on or before September 30, 2026
  • Remaining installments of $1,999,960.07 each fall due by December 31, 2026, March 31, 2027 and June 30, 2027
  • Dr. Henry Ji serves as Scilex CEO, President and Chairperson and as CEO of Vivasor

The filing

CompanyScilex Holding Co (SCLX)
Form8-K, current report
Filed with the SECJul 22, 2026, 5:30 PM ET
Accession number0001193125-26-312591

Items reported: 1.01 Material Definitive Agreement2.01 Acquisition or Disposition Completed

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 22, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.